Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.85
0.23 (14.20%)
At close: Aug 15, 2025, 3:00 PM
Inovio Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 65.34K | 116.99K | n/a | 100.76K | n/a | 102.65K | 388.45K | 225.97K | 114.94K | 124.67K | 9.15M | 784.39K | 199.07K | 839.12K | 291.7K | 272.82K | 371.12K |
Cost of Revenue | 741.67K | n/a | 775.83K | 765.86K | 828.63K | 759.73K | 175.23K | 1.03M | 1.14M | 30.18M | 1.35M | 1.36M | 1.41M | 55.98M | 1.38M | 47.09M | 70.81M | 39.04M |
Gross Profit | -741.67K | 65.34K | -658.84K | -765.86K | -727.86K | -759.73K | -72.58K | -644.33K | -917.44K | -30.06M | -1.22M | 7.79M | -625.65K | -55.78M | -540.07K | -46.8M | -70.54M | -38.67M |
Operating Income | -23.08M | -25.05M | -20.37M | -27.35M | -33.2M | -31.48M | -27.39M | -25.04M | -37.04M | -43.95M | -55.95M | -35.76M | -104.14M | -71.73M | -105.51M | -59.95M | -83.2M | -52.55M |
Interest Income | 610.64K | 808.08K | 852.59K | 1.11M | 1.31M | 1.5M | 1.82M | 1.94M | 2.17M | 2.21M | 1.89M | 1.37M | 857.67K | 669.81K | 899.46K | 766.27K | 928.11K | 769.24K |
Pretax Income | -23.52M | -19.69M | -19.38M | -25.17B | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -76.91M | -106.95M | -60.17M | -82.14M | -53.97M |
Net Income | -23.52M | -19.69B | -19.38M | -25.17B | -32.24M | -30.47M | -25M | -33.93M | -35.53M | 2.95B | -51.67M | -39.62M | -112.46M | -83.91M | -106.95M | -60.17M | -82.14M | -54.4M |
Selling & General & Admin | 8.18M | 9.02B | 6.83M | 8.61M | 9.38M | 9.81M | 10.07M | 9.93M | 13.52M | 13.89M | 13.95M | 11.82M | 48.46M | 15.95M | 14.05M | 13.16M | 12.67M | 13.88M |
Research & Development | 14.17M | 16.09B | 12.89M | 18.73M | 23.09M | 20.91M | 17.25M | 15.5M | 23.74M | 30.18M | 42.12M | 33.09M | 56.46M | 55.98M | 92.3M | 47.09M | 70.81M | 39.04M |
Other Expenses | n/a | -25.09B | n/a | n/a | n/a | n/a | n/a | -1.03M | -1.43M | -2.43M | -2.76M | -940.78K | -3.05K | -153.47K | 177.6K | -28.49K | 185.28K | 8.98K |
Operating Expenses | 22.34M | 25.12M | 19.71M | 27.35M | 32.47M | 30.73M | 27.32M | 24.4M | 37.27M | 44.07M | 56.07M | 44.91M | 104.92M | 71.93M | 106.35M | 60.24M | 83.47M | 52.93M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 177.83K | 282.32K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 480.31K | 476.37K | 466.73K | 513.03K |
Selling & Marketing Expenses | n/a | n/a | n/a | -8.61B | -10.2B | n/a | -175.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.08M | 25.12M | -20.49M | 27.35M | 33.3M | 31.48M | 27.5M | 25.43M | 37.27M | 44.07M | 56.07M | 44.91M | 104.92M | 71.93M | 106.35M | 60.24M | 83.47M | 52.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.99B | -2.79M | 1.83M | 3.97M | 7.01M | n/a | 455.3K | -136.49K | 1.28M |
Shares Outstanding (Basic) | 38.83M | 27.16M | 27.16M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M | 209.56M | 202.41M |
Shares Outstanding (Diluted) | 38.83M | 27.16M | 27.16M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M | 209.56M | 202.41M |
EPS (Basic) | -0.61 | -0.51 | -0.7 | -894.28 | -1.19 | -1.31 | -1.1 | -1.52 | -1.61 | 136.92 | -2.42 | -0.16 | -0.48 | -0.38 | -0.51 | -0.29 | -0.39 | -0.27 |
EPS (Diluted) | -0.61 | -725.11 | -0.7 | -894.28 | -1.19 | -1.31 | -1.1 | -1.52 | -1.61 | 136.92 | -2.42 | -0.16 | -0.48 | -0.38 | -0.51 | -0.29 | -0.39 | -0.27 |
EBITDA | -22.78M | -25.05B | -18.61M | -24.4M | -31.41M | -29.53M | -24.55M | -32.58M | -34.08M | -39.18M | -52.8M | -36.11M | -106.77M | -75.22M | -105.09M | -58.54M | -80.55M | -52.38M |
EBIT | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.29M | -24.72M | -33.62M | -35.22M | -40.34M | -54.15M | -37.47M | -108.18M | -76.6M | -106.47M | -59.69M | -81.67M | -53.45M |
Depreciation & Amortization | 741.67K | 743.45K | 775.83K | 765.86K | 828.63K | 759.73K | 175.23K | 1.03M | 1.14M | 1.15M | 1.35M | 1.36M | 1.41M | 1.38M | 1.38M | 1.16M | 1.12M | 1.08M |